MII IG Medikation
2027.0.0-ballot -
Germany
This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="mii-exa-medikation-medication-request-caelyx"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationRequest|2027.0.0-ballot"/>
<security>
<system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
<code value="HTEST"/>
<display value="test health data"/>
</security>
</meta>
<language value="en"/>
<text>
<status value="extensions"/>
<div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx</b></p><a name="mii-exa-medikation-medication-request-caelyx"> </a><a name="hcmii-exa-medikation-medication-request-caelyx"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-medikation-medication-request.html">MII PR Medikation MedicationRequest</a> version: 2027.0.0-ballot</p><p style="margin-bottom: 0px">Security Label: <a href="http://terminology.hl7.org/7.3.0/CodeSystem-v3-ActReason.html">test health data (Details: ActReason code HTEST = 'test health data')</a></p></div><p><b>R5: Full representation of the dosage instructions (new)</b>: </p><div><p>Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion</p>
</div><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>medication</b>: <a href="Medication-mii-exa-medikation-medication-caelyx.html">Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1</a></p><p><b>subject</b>: <a href="Patient-mii-exa-medikation-patient.html">Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)</a></p><p><b>authoredOn</b>: 2021-12-21 11:41:00+0100</p><blockquote><p><b>dosageInstruction</b></p><p><b>timing</b>: Once per 4 weeks</p><p><b>route</b>: <span title="Codes:{http://standardterms.edqm.eu 20045000}">Intravenous use</span></p><h3>DoseAndRates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Dose[x]</b></td></tr><tr><td style="display: none">*</td><td>50 mg/m2 BSA<span style="background: LightGoldenRodYellow"> (Details: UCUM codemg/m2 = 'mg/m2')</span></td></tr></table></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationRequest.renderedDosageInstruction">
<valueMarkdown
value="Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion"/>
</extension>
<status value="active"/>
<intent value="order"/>
<medicationReference>🔗
<reference value="Medication/mii-exa-medikation-medication-caelyx"/>
</medicationReference>
<subject>🔗
<reference value="Patient/mii-exa-medikation-patient"/>
</subject>
<authoredOn value="2021-12-21T11:41:00+01:00"/>
<dosageInstruction>
<timing>
<repeat>
<frequency value="1"/>
<period value="4"/>
<periodUnit value="wk"/>
</repeat>
</timing>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20045000"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="50"/>
<unit value="mg/m2 BSA"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg/m2"/>
</doseQuantity>
</doseAndRate>
</dosageInstruction>
</MedicationRequest>